Pluvicto - lutetium LU 177 vipivotide tetra 27MCI/ML

Ended Awarded Last action

Contract number
36C26126F0168
Awardee
Awarding agency
Obligated
$1,200,299

Award facts

Opportunity
  • 36C26126Q0501 Solicitation number
Contract value 50% obligated
  • $1,200,299.10 Current, with exercised options
  • $2,400,598.20 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Mather, CA, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00002 · Modification to exercise 5 addtl units $171,471
Modification $342,943
Supplemental Agreement for work within scope P00001 $685,885

About this award

Veterans Integrated Service Network 21 issued a delivery order to Novartis Pharmaceuticals Corporation on April 1, 2026, with a ceiling value of $2,400,598.20 for PLUVICTO (Lutetium Lu-177 Vipivotide Tetra), a radiopharmaceutical for metastatic castration-resistant prostate cancer, with performance completing by September 30, 2026.

The order is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), a GSA-administered multi-vendor schedule for pharmaceutical procurement across federal agencies. The delivery represents a modification to exercise five additional units under an existing call. Place of performance is Mather, CA. Pricing is firm fixed price with no set-aside applied.

Quick answers

Who was awarded contract 36C26126F0168?

36C26126F0168 was awarded to Novartis Pharmaceuticals Corporation by Veterans Integrated Service Network 21 (Veterans Health Administration) on April 1, 2026.

How much is contract 36C26126F0168 worth?

The government has obligated $1,200,299 on 36C26126F0168. Its potential value, with all options, is $2,400,598.

Is contract 36C26126F0168 an order under another contract?

Yes. 36C26126F0168 is a delivery order under 36F79720D0180, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26126F0168 competed?

The extent of competition for 36C26126F0168 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award